Why should statins prevent venous thromboembolism? A systematic literature search and a call for action
Open Access
- 4 May 2006
- journal article
- Published by Elsevier in Journal of Thrombosis and Haemostasis
- Vol. 4 (9), 1925-1927
- https://doi.org/10.1111/j.1538-7836.2006.02030.x
Abstract
No abstract availableThis publication has 14 references indexed in Scilit:
- Serum Lipid Levels and the Risk of Venous ThrombosisArteriosclerosis, Thrombosis, and Vascular Biology, 2004
- Antithrombotic Therapy for Venous Thromboembolic DiseaseChest, 2004
- Statins but not fibrates are associated with a reduced risk of venous thromboembolism: a hospital‐based case–control studyFundamental & Clinical Pharmacology, 2004
- HMG CoA reductase inhibitors and the risk of venous thrombosis among postmenopausal womenJournal of Thrombosis and Haemostasis, 2004
- Effects of lipids and lipid‐lowering therapy on hemostatic factors in patients with myocardial infarctionJournal of Thrombosis and Haemostasis, 2004
- D-Dimer Levels and Risk of Recurrent Venous ThromboembolismJAMA, 2003
- Predictive Value of D-Dimer Test for Recurrent Venous Thromboembolism After Anticoagulation Withdrawal in Subjects With a Previous Idiopathic Event and in Carriers of Congenital ThrombophiliaCirculation, 2003
- An Association between Atherosclerosis and Venous ThrombosisNew England Journal of Medicine, 2003
- Statins and the risk of idiopathic venous thromboembolismBritish Journal of Clinical Pharmacology, 2002
- Postmenopausal Hormone Therapy Increases Risk for Venous Thromboembolic Disease: The Heart and Estrogen/progestin Replacement StudyAnnals of Internal Medicine, 2000